» Articles » PMID: 36950593

The CeRNA Network Regulates Epithelial-mesenchymal Transition in Colorectal Cancer

Overview
Journal Heliyon
Specialty Social Sciences
Date 2023 Mar 23
PMID 36950593
Authors
Affiliations
Soon will be listed here.
Abstract

Epithelial-mesenchymal transition (EMT) is a biological process that transforms epithelial cells into a mesenchymal phenotype, conferring cell migration and invasion capabilities. EMT is involved in the progression and metastasis of colorectal cancer (CRC). Recently, emerging evidence has shown dysregulation of non-coding RNA (ncRNA) was linked to EMT. ncRNAs, including long non-coding RNA (lncRNA), regulate the transcription of downstream target genes (mRNA) through interaction with microRNAs (miRNAs); these are termed competitive endogenous RNA (ceRNA) networks. CeRNA dysregulation-induced EMT, which is linked to the progression and prognosis of CRC, has attracted wide attention. However, understanding the role of the regulation of the ceRNA network in the EMT of CRC remains limited. We discuss the molecular functions of lncRNA, the ceRNA networks related to miRNAs and mRNAs in EMT, as well as EMT transcription factors, such as the zinc finger E-box binding homeobox 1/2 (ZEB1/2), SNAIL, SLUG, and TWIST1/2. In addition, miRNAs and lncRNAs that directly target genes, thereby initiating different signaling pathways to promote EMT in CRC, were summarized. Clarifying the role of these molecules in EMT is critical for understanding molecular mechanisms and exploring the potential therapeutic targets of CRC.

Citing Articles

CircRNAs in Colorectal Cancer: Unveiling Their Roles and Exploring Therapeutic Potential.

Ding Y, Song X, Chen J Biochem Genet. 2025; .

PMID: 40029586 DOI: 10.1007/s10528-025-11068-5.


Deciphering the oncogenic network: how C1QTNF1-AS1 modulates osteosarcoma through miR-34a-5p and glycolytic pathways.

Zhang Y, Lun H, Zhu N, Yang N, Ding K, Chen B Front Oncol. 2025; 14():1485605.

PMID: 39850812 PMC: 11754200. DOI: 10.3389/fonc.2024.1485605.


LINC02257 regulates malignant phenotypes of colorectal cancer via interacting with miR-1273g-3p and YB1.

Park M, Jeong S, Shin C, Cha S, Yu A, Kim E Cell Death Dis. 2024; 15(12):895.

PMID: 39695079 PMC: 11655847. DOI: 10.1038/s41419-024-07259-4.


Comprehensive Multi-Omics Analysis Reveals NPC2 and ITGAV Genes as Potential Prognostic Biomarkers in Gastrointestinal Cancers.

Piroozkhah M, Zabihi M, Jalali P, Salehi Z Cancer Rep (Hoboken). 2024; 7(12):e70087.

PMID: 39690926 PMC: 11652787. DOI: 10.1002/cnr2.70087.


Circ_0001944 Targets the miR-1292-5p/FBLN2 Axis to Facilitate Sorafenib Resistance in Hepatocellular Carcinoma by Impeding Ferroptosis.

Jing F, Shi Y, Jiang D, Li X, Sun J, Guo Q Immunotargets Ther. 2024; 13:643-659.

PMID: 39624827 PMC: 11611519. DOI: 10.2147/ITT.S463556.


References
1.
Usman S, Waseem N, Nguyen T, Mohsin S, Jamal A, Teh M . Vimentin Is at the Heart of Epithelial Mesenchymal Transition (EMT) Mediated Metastasis. Cancers (Basel). 2021; 13(19). PMC: 8507690. DOI: 10.3390/cancers13194985. View

2.
Li Z, Shen J, Chan M, Wu W . TUG1: a pivotal oncogenic long non-coding RNA of human cancers. Cell Prolif. 2016; 49(4):471-5. PMC: 6496395. DOI: 10.1111/cpr.12269. View

3.
Liu A, Liu L, Lu H . LncRNA XIST facilitates proliferation and epithelial-mesenchymal transition of colorectal cancer cells through targeting miR-486-5p and promoting neuropilin-2. J Cell Physiol. 2019; 234(8):13747-13761. DOI: 10.1002/jcp.28054. View

4.
Liu X, Cui L, Hua D . Long Noncoding RNA XIST Regulates miR-137-EZH2 Axis to Promote Tumor Metastasis in Colorectal Cancer. Oncol Res. 2018; 27(1):99-106. PMC: 7848292. DOI: 10.3727/096504018X15195193936573. View

5.
Chen X, Xu X, Pan B, Zeng K, Xu M, Liu X . miR-150-5p suppresses tumor progression by targeting VEGFA in colorectal cancer. Aging (Albany NY). 2018; 10(11):3421-3437. PMC: 6286841. DOI: 10.18632/aging.101656. View